Lupin wins U.S. FDA approval for 100 mg and 200 mg modafinil tablets
AI Summary- Lupin received U.S. FDA approval for 100 mg and 200 mg modafinil tablets.
- $70.7 million was the reference product’s estimated annual U.S. sales through July 2026.
- Lupin’s tablets were approved as bioequivalent to Nuvo Pharmaceuticals’ Provigil Tablets.